Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2020-06-05 / Cells 2020 Jun;9(6)Relationship between Energy Dosage and Apoptotic Cell Death by Modulated Electro-Hyperthermia
/in Hyperthermia, International Publications /von 2020-06-02 / Sci Rep 2020 Jun;10(1):8936Dendritic cell vaccine as an alternative to opioid analgesia in patients with advanced cervical cancer.
/in Cervical Cancer, Dendritic Cells, International Publications /von 2020-05-29 / J Clin Oncol 38: 2020 (suppl; abstr e18022)Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2020-05-22 / Immunotargets Ther 2020;9:95-104Dendritic Cells and Their Role in Immunotherapy
/in Dendritic Cells, International Publications /von 2020-05-21 / Front Immunol 2020;11:924Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience
/in Brain Tumors in Children, Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2020-05-19 / Medicines (Basel) 2020 May;7(5)Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
/in International Publications, Newcastle Disease Virus /von 2020-05-14 / Gene Ther. 2020 May;Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1
/in Dendritic Cells, Glioblastoma, International Publications /von 2020-05-13 / Hum Vaccin Immunother 2020 May;:1-9Hyperthermia and protein homeostasis: Cytoprotection and cell death
/in Hyperthermia, International Publications /von 2020-05-08 / J Therm Biol 2020 Jul;91:102615
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de